Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
María Isabel Benítez‐Carabante, Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Júlia Marsal(Hospital Sant Joan de Déu Barcelona), Cristina Beléndez(Hospital General Universitario Gregorio Marañón), Ivan Lopez(Hospital de Sant Pau), Antonio Pérez‐Martínez(Hospital Universitario La Paz), María Luz Uria Oficialdegui(Vall d'Hebron Hospital Universitari), Blanca Molina(Hospital Infantil Universitario Niño Jesús), José María Fernandez Navarro(Hospital Universitari i Politècnic La Fe), Melissa Panesso(Vall d'Hebron Institut de Recerca), Pilar Palomo(Hospital Universitario Central de Asturias), David Bueno(Hospital Universitario La Paz)
Cited by 13
Related Papers
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
|Haematologica|2014|389
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
|Journal of Allergy and Clinical Immunology|2017|318